Navigation Links
Zero Patient Infections Reported as D.I.S.C. Spine and Sports Center Sets New Standard for Specialty Hospitals
Date:3/25/2008

MARINA DEL REY, Calif., March 25 /PRNewswire/ -- D.I.S.C. Spine and Sports Center, proudly announces its medical center is "infection free" after an initial 18 months of operation where over 1,200 procedures have been performed, according to Dr. Robert S. Bray Jr., founding director and CEO. The outpatient specialty hospital is a fully-integrated medical group providing next generation diagnostics, conservative care, sports medicine and rehabilitation along with state-of-the-art digital ORs that offer minimally invasive spine procedures and advanced arthroscopic surgeries.

With the explicit goal of minimizing the risk of infection in the 7,200-square foot surgery center, Dr. Bray made a strategic decision to install a $750,000 environmental air conditioning system throughout the center. Special attention was given to the three ultra clean operating rooms installing individual true 99.71% efficient HEPA filters to further eliminate any comingling of bacteria. With 30 air exchanges/per hour this filter exceeds the industry standard.

As an added level of protection, D.I.S.C. recently installed UVC Emitters (ultraviolet) to all critical area air moving units to destroy incoming airborne germs, bacteria and microorganisms including the highly-lethal anthrax. This level of protection is unprecedented in a medical facility and is the same type of system used by the CDC.

"This is a highly-significant accomplishment and we are extremely proud of our achievement," Dr. Bray said. "Our goal has been to redefine patient care and we have succeeded. By design, we implemented extraordinary measures to ensure the safety of our patients. In over 18 months of operation, we have clearly demonstrated that the procedures, protocols and technologies we have employed can make a dramatic impact in saving lives. We have proven the ability to reduce the risk of infection, which is reaching epidemic proportions today in the hospital environment."

Moreover, very stringent policies were developed to address the basic functioning and hygiene of the surgery center. These protocols encompass patient contact, hand washing, outside clothing regulations along with minimal use of catheters. D.I.S.C. has also begun pre-screening high-risk patients for MRSA.

In a study released last spring, the CDC estimated there are 4.5 hospital infections for every 100 patient admissions resulting in nearly 100,000 deaths. With the increased resistance to infection-fighting drugs, especially the potent MRSA bacteria, these figures are alarming.

About D.I.S.C.: D.I.S.C. was founded by Dr. Robert S. Bray, Jr. one of the country's preeminent neurological spinal surgeons specializing in minimally invasive procedures. In his 26-year-career, he has performed more than 9,000 micro procedures. The Official Medical Center of the Los Angeles Kings, D.I.S.C. is redefining patient care by providing a multidisciplinary center that has the expertise of a variety of specialists from the fields of spinal neurosurgery, orthopedic surgery, physical medicine, pain management and chiropractic services all working together to find the best solution for each individual. For more information please contact D.I.S.C. at (310) 574-0400 or visit their website at: http://www.discmdgroup.com.


'/>"/>
SOURCE D.I.S.C. Spine and Sports Center
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Fluctuating eye pressure associated with visual field deterioration in glaucoma patients
2. Comparison of obstetric outcomes between on-call and patients own obstetricians
3. Vision restoration therapy shown to improve brain activity in brain injured patients
4. Diabetes appears to increase risk of death for patients with acute coronary syndromes
5. Ambulatory oxygen rarely a benefit in COPD patients without resting hypoxemia
6. Restricting Blood Flow May Help Heart Bypass Patients
7. Patients with Medicaid and those lacking insurance have higher risk of advanced laryngeal cancer
8. Study provides hope that some transplant patients could live free of antirejection drugs
9. Study provides hope that some transplant patients could live free of anti-rejection drugs
10. Longer ambulance journeys boost death risk for seriously ill patients
11. Expenses Overshadow Optimism for Kidney Failure Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/20/2017)... ... September 20, 2017 , ... Collins Concrete Coatings announced that ... rely on safety and cleanliness. This unique flooring system uses silver ion technology ... for centuries for its antimicrobial properties. Unlike antibiotics, which kill specific microorganisms, silver ...
(Date:9/20/2017)... ... September 20, 2017 , ... Renal Support Network’s annual essay ... kidney disease. The theme “Describe a positive decision that you have made about ... meet only one qualification— to have been diagnosed with chronic kidney disease. This ...
(Date:9/20/2017)... ... September 20, 2017 , ... ... medical device compliance and commercialization, has just released a new white paper ... is more adamant than ever about medical device, pharmaceutical, and combination product ...
(Date:9/20/2017)... ... September 20, 2017 , ... Demand generation pioneer True ... edition of MarTech: The Marketing Tech Conference October 2–4, at the Hynes Convention ... speakers — representing such thought-leading companies as JP Morgan Chase, GE Digital, ...
(Date:9/20/2017)... ... September 20, 2017 , ... As part ... company recently unveiled a redesigned website. The new site – still located at ... owners, architects, contractors and other industry users that Garland serves. , After an ...
Breaking Medicine News(10 mins):
(Date:9/12/2017)... MOUNTAIN LAKES, N.J. , Sept. 12, 2017  Consumer reviews ... Embrace Hearing as the number one company for hearing ... Oticon™, ReSound™ and fifteen other brands. ... Embrace Hearing Named #1 by Consumers For Hearing Aids ... Embrace Hearing is an online store that ...
(Date:9/9/2017)... , Sept. 9, 2017  Eli Lilly and ... primary and secondary endpoint data for lasmiditan, an investigational, ... which demonstrated statistically significant improvements compared to placebo in ... highlighted today at the 18th Congress of the International ... "The data presented today demonstrate lasmiditan,s potential ...
(Date:9/7/2017)... STOCKHOLM , Sept. 7, 2017 NuvoAir ... Air Smart Spirometer, announced today a partnership with Novartis Pharma ... partnership solidifies NuvoAir,s position as the leading mobile spirometry platform ... respiratory patients. ... spirometry test ...
Breaking Medicine Technology: